Tissue regeneration and wound care in Leeds City Region
Develop and commercialise new tissue regeneration and wound care technologies and access a rapidly developing market within the health and medical technology sector.
Leeds City Region is a perfect opportunity to test and translate your tissue regeneration and wound care technologies, products and devices into use in the NHS (National Health Service) and private healthcare sector.
It is an ideal location for your medtech business with:
access to all the skills you need
a strong entrepreneurial community
a world-leading cluster of specialist research and clinical organisations
Access all this to support you through the lifecycle of your investment, from R&D to commercialisation of your technologies.
Leeds City Region (West Yorkshire)
Foreign direct investment
MedTech, Healthcare and life sciences
Sector and market opportunity
There is a growing need for new products and technologies that can accelerate repair and regeneration of human tissue. The annual cost to the NHS of managing wounds and associated comorbidities is £5.3 billion. Leeds City Region offers expertise in regenerative and personalised medicine, wound care, orthopaedics and dentistry, tissue scaffolds and technology convergence. The region is primed to support investing companies from concept to commercialisation, including fundamental research, feasibility studies, clinical trials and manufacturing.
Regenerative medicine has enormous potential. The global wound care market is projected to reach £20.2 billion by 2026 from £14 billion in 2021, at a compound annual growth rate of 7.6% during the forecast period.
The UK cell and gene therapy market is predicted to increase from £300 million to about £10 billion by 2035.
The UK is the third largest medical device market in Europe, and the sixth biggest globally. From an estimated value of £7 billion in 2015, it now exceeds £12 billion.
Located in the centre of the UK, Leeds City Region offers easy access to a cluster of international firms and to over 650 health and life sciences companies, including 250 medtech and 65 digital health companies. The cluster features a broad range of capabilities such as artificial intelligence, medical devices, digital health, regenerative medicine, biomaterials, tissue scaffolds, bioengineering, and cell culture. The Leeds City Region is also home to five NHS headquarters including NHS England, NHSX and NHS Digital.
Fly to major cities within the UK, Europe and worldwide via Leeds-Bradford Airport.
Connect by road to the Midlands in 2 hours and London in under 4 hours, via the M1.
Travel to London in just over 2 hours via fast and frequent rail links.
A business can reach 76% of the UK population by HGV in 4.5 hours.
Local talent and skills
Leeds City Region has the largest workforce in medtech-related industries outside of the South East of England with 7,000 people employed.
Five higher education institutes in the region offer courses linked to the tissue regeneration and wound care sector.
About 21,000 graduates per year are ready to join the workforce, with degrees in related subjects such as medicine and dentistry and biological sciences.
Research and expertise
From fundamental research to commercialisation, Leeds City Region has everything to take technologies from concept to market. Major innovation centres offer expertise in the tissue repair and regeneration field and capabilities to help your company.
- Centre for Skin Sciences at the University of Bradford
- Centre for Biomedical Science Research at Leeds Beckett University
- Institute of Medical and Biological Engineering at the University of Leeds
- Grow Medtech at the University of Leeds
- Institute of Skin Integrity and Infection Prevention at the University of Huddersfield
The nationally-funded EPSRC Centre for Doctoral Training in Tissue Engineering and Regenerative Medicine is based at the University of Leeds. It develops regenerative therapies and devices as well as providing training for the medical and biological engineers of the future.
Local and national government support
The UK government’s Life Sciences Vision aims to tackle future disease challenges including cancer, obesity, dementia and ageing; secure jobs and investment; and transform the UK into the leading global hub for life sciences. It will target areas where the UK has, or could develop, a competitive advantage, such as cell and gene therapies, oligonucleotides, viral vectors, advanced diagnostics, and wound care. Local support is available through the Leeds City Region Enterprise Partnership.
DePuy Synthes (part of Johnson & Johnson)
DePuy Synthes is one of the largest orthopaedics companies in the world. It has a long-standing research partnership with the world-leading Institute of Medical and Biological Engineering at the University of Leeds. This has led to improved understanding of joint replacements for millions of patients worldwide, new simulation test methods and equipment, and improved international ISO standards.
Tissue Regenix is a leading medical devices company in the field of regenerative medicine and manufactures tissue repair and regeneration products for wound care and orthopaedics applications and other medical areas. Tissue Regenix was formed in 2006 as a spin-out from the University of Leeds. The company has a manufacturing centre based in Leeds and is now listed on the London Stock Exchange with revenue reaching £13 million in 2019.
Systagenix develops advanced wound care products for the management and healing of chronic and acute surgical wounds. The company offers a wide range of wound care products to meet the needs of health care professionals and patients. It supplies more than 20 million wound dressings a month in more than 100 countries.
Biomanufacturing in Tees Valley
Tees Valley is driving UK clean growth, converting sustainable feedstocks into high-value biopharmaceuticals, food and feed, biofuels and biochemical products.
Kings Hall Life Sciences Park in Belfast, Northern Ireland
An opportunity to invest in the regeneration of Kings Hall Life Sciences Park. This project is a significant economic driver in the life sciences sector and it's already attracted government funding.
Rehabilitation in Leicester and Leicestershire
Develop and commercialise rehabilitation technologies that address both complex trauma and chronic conditions
Vaccine development and manufacture in Liverpool City Region
Develop and validate new vaccines and vaccine technologies that will improve the quality of life for people around the globe.
Cell and gene therapy in Hertfordshire
Design, develop and supply transformative advanced therapies, all from the largest cell and gene therapy cluster outside the USA.
Healthy ageing and longevity in the North East
Exploit the growing national and international demand for new products and services that support health and independence into older age.
Precision biomarkers and diagnostics in Northern Ireland
Launch your biomarker journey and develop advanced precision diagnostics in Northern Ireland.
Medtech health in Wales
Develop and commercialise new medical and healthcare technologies that will improve the quality of life for people around the world
Diagnostics and early intervention for healthy ageing
Meet the growing demand for digital and molecular diagnostics innovations, and smart, assistive technologies, to support early intervention in ageing diseases
Data analytics and artificial intelligence applications in Leeds City Region
Transform society, our lives and your business by exploiting the growing demand for data analytics and artificial intelligence.
Speak to us
The government is identifying new projects across the whole of the UK. Investors who are interested in our projects can find out more by contacting us.Get in touch